Childhood, adolescent and young adult cancer and the prevalence of autism or ADHD: a systematic review and meta-analysis protocol
Year: 2026
Type: article
Study design: Study Protocol
Abstract: Background In the United Kingdom, over 1,600 children aged 0–14 years and 2,100 adolescents and young adults aged 15–24 years receive a diagnosis of cancer every year. Five-year survival has increased over time, and therefore understanding the late effects of cancer and its treatment is crucial. Social and neurocognitive difficulties (such as inattention, executive dysfunction or impaired working memory) have been identified among a proportion of young people who have survived cancer. However, co-occurring neurodevelopmental conditions have been less well studied. The aim of this systematic review is to examine the likelihood of receiving an autism or attention deficit hyperactivity disorder (ADHD) diagnosis in children, teenagers and young adults (CTYA) impacted by cancer or benign brain tumours. Methods This protocol has been reported according to PRISMA-P guidelines. Our search strategy will use terms related to the population (children and young people up to the age of 39 years at the time of cancer or brain tumour diagnosis), exposure (past or present diagnosis of cancer or brain tumour) and outcome (diagnosis of autism or ADHD at any time point). We will search PUBMED, CENTRAL, EMBASE, PsychINFO, CINAHL and Web of Science. Quantitative study designs in the English language, including cross-sectional studies and longitudinal case–control or cohort studies will be included. There will be no restrictions on location or publication date. If sufficient studies are identified, we will undertake a meta-analysis to determine the prevalence of autism and ADHD in CTYA with cancer or brain tumours, and whether this prevalence varies according to cancer type. Discussion To the authors’ knowledge, this will be the first systematic review examining the likelihood or prevalence of autism or ADHD in CTYA with cancer. Understanding this has important implications for the care of young people with cancer, including raising awareness of autism and ADHD amongst clinicians and families, streamlining pathways to a neurodevelopmental diagnosis and advocating for the adaptation of cancer care for neurodivergent young people. Systematic review registration PROSPERO registration number CRD42025644175.
Source: Systematic Reviews
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,090
Awards: G1483213741, G1798610363
OpenAlex ID: W7237083321
